Search & Filter
News Type
Topic
Disease
Population
NFID Launches Updated Website on Disease Prevention and Treatment
Redesigned site aims to empower the public and healthcare professionals with information to make informed decisions
The Double Helix, Summer 2023
Quarterly eNewsletter covering: NFID 50th Anniversary, New and Improved NFID Website, Flu Awareness Night at Washington Nationals, and more …
Schaffner Report: What Adults Should Know about New RSV Vaccines
NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton, CAE, about new vaccines for RSV
Highlights and Key Takeaways from 2023 Annual Conference on Vaccinology Research
The 2023 ACVR featured new scientific findings on COVID-19, respiratory syncytial virus (RSV), influenza, and more, as decades of research are paying off
Expert Insights on Advances in RSV Prevention and Treatment
New tools for the prevention and treatment of respiratory syncytial virus (RSV) are moving through the development pipeline
Experts to Explore Advances in RSV, COVID-19, and Flu Prevention and Treatment
Annual Conference on Vaccinology Research will feature latest science
Infectious Disease Experts Available to Discuss Hepatitis B Prevention
NFID has spokespersons and resources to help increase awareness about the importance of adult vaccination and screening for hepatitis B
B Protected: Hepatitis Vaccination and Screening for All Adults
May is Hepatitis Awareness Month and May 19 marks Hepatitis Testing Day, a time to increase awareness about adult vaccination and screening recommendations for hepatitis B